Columbia Laboratories Cash from Investing Quarterly:
-0.055M for Dec. 31, 2012Columbia Laboratories Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -0.055M |
| Sept. 30, 2012 | -0.1209M |
| June 30, 2012 | -0.0686M |
| March 31, 2012 | -0.9763M |
| Dec. 31, 2011 | -0.7466M |
| Sept. 30, 2011 | -15.04M |
| June 30, 2011 | 2.479M |
| March 31, 2011 | -0.0047M |
| Dec. 31, 2010 | -0.0075M |
| Sept. 30, 2010 | 35.21M |
| June 30, 2010 | -0.0059M |
| March 31, 2010 | -0.0012M |
| Dec. 31, 2009 | -0.0018M |
| Sept. 30, 2009 | -0.0046M |
| June 30, 2009 | -0.0385M |
| March 31, 2009 | -0.0049M |
| Dec. 31, 2008 | 0.0566M |
| Sept. 30, 2008 | -0.2847M |
| June 30, 2008 | -0.0284M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
CBRX Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Hi-Tech Pharmacal | -3.831M |
| SciClone Pharmaceuticals | -0.167M |
| Sagent Pharmaceuticals | -6.651M |
CBRX Cash from Investing Quarterly Rankings
| Overall |
83rd percentile 1267 of 7590 |
| Sector |
67th percentile 214 of 651 in Healthcare |
| Industry |
70th percentile 19 of 65 in Drug Manufacturers - Specialty & Generic |
CBRX Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -15.04M | Sep 2011 |
| Maximum | 35.21M | Sep 2010 |
| Average | 1.072M |
